CD44 and cancer: Finally, the therapeutic potential of lectins extends beyond cancer therapy, raising the question of whether MIC1 and MIC4 might similarly influence immune cells, as seen in mouse dendritic cells and macrophages that respond to these microneme proteins by producing the pro-inflammatory cytokine IL-12, thus promoting a protective T helper 1 (Th1) immune response against T. gondii.